(1) CSL must, before the transition:
(a) apply to the National Companies and Securities Commission under subsection 85(1) of the Companies Act 1981 to be registered as a company limited by shares within the meaning of that Act; and
(b) apply to the National Companies and Securities Commission under subsection 55(1) of the Companies Act 1981 for the reservation of the name "Commonwealth Serum Laboratories Limited"; and
(c) lodge with the National Companies and Securities Commission a proposed memorandum, and proposed articles, for CSL; and
(d) if the rights attached to shares included in a class of shares under subsection 9(4) are not provided for in the memorandum or articles, lodge with the National Companies and Securities Commission the statement referred to in subsection 124(1) of the Companies Act 1981 .
(2) Subject to the regulations, the application mentioned in paragraph ( 1)(a) must be accompanied by the documents required by subsection 85(4) of the Companies Act 1981 to accompany such an application.
(3) The applications mentioned in paragraphs ( 1)(a) and (b) must be made to the National Companies and Securities Commission by delivering them to the office of the Corporate Affairs Commission for the Australian Capital Territory and the documents mentioned in paragraphs ( 1)(c) and (d) and subsection ( 2) must be lodged with the National Companies and Securities Commission by lodging them at that office.
(4) CSL is to be taken to be entitled to make the applications referred to in paragraphs ( 1)(a) and (b), and to lodge the documents mentioned in paragraph ( 1)(c) and subsection ( 2).
(5) The National Companies and Securities Commission is to be taken:
(a) to have been required to reserve the name "Commonwealth Serum Laboratories Limited" under subsection 55(2) of the Companies Act 1981 ; and
(b) to have so reserved that name immediately after the making of the application mentioned in paragraph ( 1)(b).